Location

Please check the individual session for location or broadcast availability.  

Frequency

Semi-monthly

Series Director

Michael C. Braun, MD

Series Co-Director

Target Audience

Needs Statement

Classification systems in renal pathology are continually evolving, and staying current is essential for accurate diagnosis and treatment planning. This series ensures that learners utilize the most up-to-date classification frameworks, such as those for lupus nephritis, which has undergone multiple revisions in the past decade, and kidney transplant rejection. Because pathologic classification directly informs clinical decision-making, shared understanding across specialties and training levels is critical. Foundational knowledge, including what defines an “adequate” biopsy sample and the standard histopathologic techniques, is essential for trainees. For experienced providers, the series also explores emerging technologies that are advancing the field. These topics are addressed through core educational sessions and case-based reviews. Active participation by nephrologists, pathologists, and rheumatologists enhances the implementation of classification systems and supports comprehensive, guideline-driven care, particularly in complex conditions like lupus nephritis and transplant rejection.

Educational Methods

Educational methods will include case presentations and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Describe the current classification systems used in renal pathology—including the various classes of lupus nephritis and the Banff criteria for kidney transplant rejection—and explain how these classifications guide clinical decision-making.
• Define what constitutes an adequate renal biopsy sample and identify the standard histopathologic techniques used in routine kidney pathology evaluation.
• Recognize and discuss emerging histopathologic technologies and techniques that are advancing the field of kidney pathology and improving diagnostic precision.
• Develop patient-specific treatment strategies based on histopathologic findings and current disease-specific care guidelines, with emphasis on multidisciplinary collaboration.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Baylor College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator